Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.5000
+0.0050 (1.01%)
Sep 18, 2026, 1:20 PM AEST
Cambium Bio Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Operating Revenue | 0.64 | 0.67 | 0.13 | - |
Other Revenue | 0.58 | 0.1 | 0.05 | 1.01 |
| 1.23 | 0.77 | 0.18 | 1.01 | |
Revenue Growth | 58.17% | 337.80% | -82.55% | - |
Cost of Revenue | 0.19 | 0.2 | 0.05 | - |
Gross Profit | 1.04 | 0.57 | 0.13 | 1.01 |
Selling, General & Admin | 1.68 | 2.08 | 1.7 | 1.88 |
Research & Development | 3.13 | 2.68 | 0.14 | 0.37 |
Other Operating Expenses | - | - | - | -0.03 |
Operating Expenses | 4.81 | 4.76 | 1.84 | 2.22 |
Operating Income | -3.77 | -4.19 | -1.71 | -1.2 |
Interest Expense | -0 | -0.02 | -0.2 | -0.26 |
Interest & Investment Income | 0.01 | 0.03 | 0 | 0 |
Currency Exchange Gain (Loss) | 0.05 | -0.03 | 0.01 | -0 |
Other Non Operating Income (Expenses) | -0.01 | -0.01 | -0.08 | -0.09 |
EBT Excluding Unusual Items | -3.73 | -4.23 | -1.96 | -1.56 |
Merger & Restructuring Charges | - | 0 | -0.54 | -0.08 |
Gain (Loss) on Sale of Investments | -0.37 | 0.38 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 |
Other Unusual Items | - | - | 0.24 | -0.07 |
Pretax Income | -4.1 | -3.84 | -2.26 | -1.69 |
Net Income | -4.1 | -3.84 | -2.26 | -1.69 |
Net Income to Common | -4.1 | -3.84 | -2.26 | -1.69 |
Net Income Growth | - | - | - | - |
Shares Outstanding (Basic) | 24 | 18 | 4 | 3 |
Shares Outstanding (Diluted) | 24 | 18 | 4 | 3 |
Shares Change | 30.54% | 338.32% | 36.12% | - |
EPS (Basic) | -0.17 | -0.21 | -0.54 | -0.55 |
EPS (Diluted) | -0.17 | -0.21 | -0.54 | -0.55 |
EPS Growth | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Free Cash Flow | -2.81 | -5.25 | -0.16 | -0.66 |
Free Cash Flow Per Share | -0.12 | -0.29 | -0.04 | -0.22 |
Gross Margin | 84.47% | 74.09% | 72.59% | 100.00% |
Operating Margin | -307.87% | -540.83% | -964.22% | -118.76% |
Profit Margin | -334.20% | -496.11% | -1274.48% | -166.33% |
Free Cash Flow Margin | -229.25% | -677.17% | -88.06% | -65.12% |
EBITDA | -3.77 | -4.19 | -1.71 | -1.2 |
EBITDA Margin | - | - | - | -118.13% |
D&A For EBITDA | 0 | 0.01 | 0 | 0.01 |
EBIT | -3.77 | -4.19 | -1.71 | -1.2 |
EBIT Margin | - | - | - | -118.76% |